Clinical outcomes show improved transfusion independence with hydroxyurea in beta-thalassaemia patients, indicating potential benefits.
Clinical outcomes of hydroxyurea (hydroxycarbamide)-induced transfusion independence in patients with β-thalassaemia syndromes.
No takes yet. Share an insight, caveat, or question.
Sevanthini et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: